Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer
Public ClinicalTrials.gov record NCT02566993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Study identification
- NCT ID
- NCT02566993
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- PharmaMar
- Industry
- Enrollment
- 613 participants
Conditions and interventions
Conditions
Interventions
- Lurbinectedin (PM01183) Drug
- Doxorubicin (DOX) Drug
- Cyclophosphamide (CTX) Drug
- Vincristine (VCR) Drug
- Topotecan Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 29, 2016
- Primary completion
- Feb 23, 2020
- Completion
- Feb 23, 2020
- Last update posted
- Oct 27, 2021
2016 – 2020
United States locations
- U.S. sites
- 29
- U.S. states
- 20
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Oncology | Birmingham | Alabama | 35243 | — |
| Ironwood Physicians P.C. dba Ironwood Cancer & Research Centers | Chandler | Arizona | 85224 | — |
| St Jude Hospital Yorba Linda dba St Joseph Heritage Healthcare | Fullerton | California | 92835 | — |
| Loma Linda University Medica! Center | Loma Linda | California | 92354 | — |
| Innovative Clinical Research Institute (ICRI) | Whittier | California | 90603 | — |
| Boca Raton Regional Hospital Lynn Cancer Institute | Boca Raton | Florida | 33486 | — |
| Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center | Fort Lauderdale | Florida | 33308 | — |
| H. Lee Moffitt Cancer Center & Research Institute | Tampa | Florida | 33612 | — |
| Joliet Oncology-Hematology Associates, Ltd. | Joliet | Illinois | 60435 | — |
| Healthcare Research Network III, LLC | Tinley Park | Illinois | 60487 | — |
| Carle Cancer Center | Urbana | Illinois | 61801 | — |
| Norton Cancer Institute | Louisville | Kentucky | 40202 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| East Jefferson Hematology-Oncology Metairie Physicians Services, Inc | Metairie | Louisiana | 70006 | — |
| Anne Arundel Medical Center Oncology and Hematology | Annapolis | Maryland | 21401 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| QUEST Research Institute | Royal Oak | Michigan | 48073 | — |
| Comprehensive Cancer Centers of Nevada | Las Vegas | Nevada | 89169 | — |
| Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital | Lebanon | New Hampshire | 03756 | — |
| Summit Medical Group, P.A. | Florham Park | New Jersey | 07932 | — |
| FirstHealth Outpatient Cancer Center | Pinehurst | North Carolina | 28374 | — |
| Gabrail Cancer Center Research | Canton | Ohio | 44718 | — |
| Oklahoma Cancer Specialists and Research Institute, LLC | Tulsa | Oklahoma | 74146 | — |
| Associates in Hematology and Oncology, P.C. | Upland | Pennsylvania | 19013 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Tyler Hematology-Oncology PA | Tyler | Texas | 75701 | — |
| Medical Oncology Associates PS (dba Summit Cancer Centers) | Spokane | Washington | 99208 | — |
| MultiCare Institute for Research & Innovation | Tacoma | Washington | 98405 | — |
| Froedtert Hospital & the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 131 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02566993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2021 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02566993 live on ClinicalTrials.gov.